Nitrogen

Industry

CPC
C12N2310/3535

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2310/00Structure or type of the nucleic acid

Current Industry

C12N2310/3535Nitrogen

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Conjugated antisense compounds and their use
- Patent number 12,275,940
- Issue date Apr 15, 2025
- Ionis Pharmaceuticals, Inc.
- Michael Oestergaard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Exon skipping compositions for treating muscular dystrophy
- Patent number 11,932,851
- Issue date Mar 19, 2024
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Conjugated antisense compounds and their use
- Patent number 11,725,208
- Issue date Aug 15, 2023
- Ionis Pharmaceuticals, Inc.
- Michael Oestergaard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense nucleic acids
- Patent number 11,053,497
- Issue date Jul 6, 2021
- Nippon Shinyaku Co., Ltd.
- Tatsushi Wakayama
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALA...
- Patent number 10,968,452
- Issue date Apr 6, 2021
- Alnylam Pharmaceuticals, Inc.
- Gregory Hinkle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Exon skipping compositions for treating muscular dystrophy
- Patent number 10,907,154
- Issue date Feb 2, 2021
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense polynucleotides to induce exon skipping and methods of tr...
- Patent number 9,777,271
- Issue date Oct 3, 2017
- The University of Chicago
- Elizabeth McNally
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions involving miRNA and miRNA inhibitor molecules
- Patent number 9,506,061
- Issue date Nov 29, 2016
- Asuragen, Inc.
- David Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense polynucleotides to induce exon skipping and methods of tr...
- Patent number 9,499,817
- Issue date Nov 22, 2016
- The University of Chicago
- Elizabeth McNally
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions involving miRNA and miRNA inhibitor molecules
- Patent number 9,447,414
- Issue date Sep 20, 2016
- Asuragen, Inc.
- David Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions involving miRNA and miRNA inhibitor molecules
- Patent number 9,382,537
- Issue date Jul 5, 2016
- Asuragen, Inc.
- David Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aptamer which selectively binds to ERBB2 receptor and uses thereof
- Patent number 9,309,515
- Issue date Apr 12, 2016
- POSTECH Academy-Industry Foundation
- Jung Hwan Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Exon skipping compositions for treating muscular dystrophy
- Patent number 9,217,148
- Issue date Dec 22, 2015
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions involving miRNA and miRNA inhibitor molecules
- Patent number 8,765,709
- Issue date Jul 1, 2014
- Asuragen, Inc.
- David Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions involving miRNA and miRNA inhibitor molecules
- Patent number 8,563,708
- Issue date Oct 22, 2013
- Asuragen, Inc.
- David Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions involving miRNA and miRNA inhibitor molecules
- Patent number 8,173,611
- Issue date May 8, 2012
- Asuragen Inc.
- David Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions involving miRNA and miRNA inhibitor molecules
- Patent number 8,058,250
- Issue date Nov 15, 2011
- Asuragen, Inc.
- David Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions involving miRNA and miRNA inhibitor molecules
- Patent number 7,960,359
- Issue date Jun 14, 2011
- Asuragen, Inc.
- David Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis, deprotection, analysis and purification of RNA and riboz...
- Patent number 7,041,817
- Issue date May 9, 2006
- Sirna Therapeutics, Inc.
- Nassim Usman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
2′ Modified oligonucleotides
- Patent number 6,911,540
- Issue date Jun 28, 2005
- ISIS Pharmaceuticals, Inc.
- Chris A. Buhr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Polymerase III-based expression of therapeutic RNAS
- Patent number 6,852,535
- Issue date Feb 8, 2005
- Sirna Therapeutics, Inc.
- James D. Thompson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Synthesis, deprotection, analysis and purification of RNA and riboz...
- Patent number 6,649,751
- Issue date Nov 18, 2003
- Sirna Therapeutics, Inc.
- Nassim Usman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Base-modified enzymatic nucleic acid
- Patent number 6,528,639
- Issue date Mar 4, 2003
- Ribozyme Pharmaceuticals, Inc.
- Nassim Usman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
2′ Modified oligonucleotides
- Patent number 6,476,205
- Issue date Nov 5, 2002
- ISIS Pharmaceuticals, Inc.
- Chris A. Buhr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Synthesis, deprotection, analysis and purification of RNA and riboz...
- Patent number 6,469,158
- Issue date Oct 22, 2002
- Ribozyme Pharmaceuticals, Incorporated
- Nassim Usman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method and reagent for inhibiting herpes simplex virus replication
- Patent number 6,440,719
- Issue date Aug 27, 2002
- Ribozyme Pharmaceuticals, Inc.
- Kenneth G. Draper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ribozyme treatment of diseases or conditions related to levels of i...
- Patent number 6,436,644
- Issue date Aug 20, 2002
- Ribozyme Pharmaceuticals, Inc.
- Susan Grimm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis, deprotection, analysis and purification for RNA and ribo...
- Patent number 6,437,117
- Issue date Aug 20, 2002
- Ribozyme Pharmaceuticals, Inc.
- Nassim Usman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method and reagent for inhibiting herpes simplex virus replication
- Patent number 6,432,704
- Issue date Aug 13, 2002
- Ribozyme Pharmaceuticals, Inc.
- Kenneth G. Draper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ribozyme treatment of diseases or conditions related to levels of N...
- Patent number 6,410,224
- Issue date Jun 25, 2002
- Ribozyme Pharmaceuticals, Inc.
- Dan T. Stinchcomb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TRE...
- Publication number 20250179495
- Publication date Jun 5, 2025
- The University of Chicago
- Elizabeth McNally
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20250145991
- Publication date May 8, 2025
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antisense Nucleic Acids
- Publication number 20250145997
- Publication date May 8, 2025
- Nippon Shinyaku co., Ltd.
- Tatsushi Wakayama
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TRE...
- Publication number 20240327844
- Publication date Oct 3, 2024
- The University of Chicago
- Elizabeth McNally
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
- Publication number 20240279664
- Publication date Aug 22, 2024
- Ionis Pharmaceuticals, Inc.
- Michael Oestergaard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20220364093
- Publication date Nov 17, 2022
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE NUCLEIC ACIDS
- Publication number 20220162604
- Publication date May 26, 2022
- NIPPON SHINYAKU CO., LTD.
- Tatsushi Wakayama
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20220056442
- Publication date Feb 24, 2022
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Treatment Of Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steat...
- Publication number 20210301287
- Publication date Sep 30, 2021
- The Trustees of the University of Pennsylvania
- Zoltan Arany
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20210180064
- Publication date Jun 17, 2021
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE
- Publication number 20200392509
- Publication date Dec 17, 2020
- Ionis Pharmaceuticals, Inc.
- Michael Oestergaard
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE NUCLEIC ACIDS
- Publication number 20200149040
- Publication date May 14, 2020
- NIPPON SHINYAKU CO., LTD.
- Tatsushi Wakayama
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20200040336
- Publication date Feb 6, 2020
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20190330624
- Publication date Oct 31, 2019
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SYNTHESIS OF HIGH DENSITY MOLECULAR DNA BRUSHES VIA ORGANIC-PHASE R...
- Publication number 20190292310
- Publication date Sep 26, 2019
- Northeastern University
- Ke ZHANG
- C08 - ORGANIC MACROMOLECULAR COMPOUNDS THEIR PREPARATION OR CHEMICAL WORKING-...
Information Patent Application
ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TRE...
- Publication number 20190194659
- Publication date Jun 27, 2019
- The University of Chicago
- Elizabeth McNally
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20190177724
- Publication date Jun 13, 2019
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
- Publication number 20190062748
- Publication date Feb 28, 2019
- Arrowhead Pharmaceuticals, Inc.
- David B. Rozema
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antisense Polynucleotides to Induce Exon Skipping and Method of Tre...
- Publication number 20180327743
- Publication date Nov 15, 2018
- The University of Chicago
- Elizabeth McNally
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TR...
- Publication number 20180037889
- Publication date Feb 8, 2018
- The University of Chicago
- Elizabeth McNally
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20180016574
- Publication date Jan 18, 2018
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20180002689
- Publication date Jan 4, 2018
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20170369876
- Publication date Dec 28, 2017
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SELF-ASSEMBLED, ELECTRONICALLY-FUNCTIONAL NUCLEIC ACID NANOSTRUCTUR...
- Publication number 20170294608
- Publication date Oct 12, 2017
- THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
- Simon Alexander Vecchioni
- B82 - NANO-TECHNOLOGY
Information Patent Application
POLYNUCLEOTIDE AGENTS TARGETING AMINOLEVULINIC ACID SYNTHASE-1 (ALA...
- Publication number 20170204418
- Publication date Jul 20, 2017
- Alnylam Pharmaceuticals, Inc.
- Gregory Hinkle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
- Publication number 20170022497
- Publication date Jan 26, 2017
- Arrowhead Pharmaceuticals, Inc.
- David B. Rozema
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
- Publication number 20150344881
- Publication date Dec 3, 2015
- MIRNA THERAPEUTICS, INC.
- David BROWN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antisense Polynucleotides to Induce Exon Skipping and Methods of Tr...
- Publication number 20150225718
- Publication date Aug 13, 2015
- The University of Chicago
- Elizabeth McNally
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
APTAMER WHICH SELECTIVELY BINDS TO ERBB2 RECEPTOR AND USES THEREOF
- Publication number 20150005368
- Publication date Jan 1, 2015
- KOREA FOOD & DRUG ADMINISTRATION
- Jung Hwan Lee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
- Publication number 20140348907
- Publication date Nov 27, 2014
- ASURAGEN, INC.
- David Brown
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Conjugated antisense compounds and their use

Exon skipping compositions for treating muscular dystrophy

Conjugated antisense compounds and their use

Antisense nucleic acids

Polynucleotide agents targeting aminolevulinic acid synthase-1 (ALA...

Exon skipping compositions for treating muscular dystrophy

Antisense polynucleotides to induce exon skipping and methods of tr...

Methods and compositions involving miRNA and miRNA inhibitor molecules

Antisense polynucleotides to induce exon skipping and methods of tr...

Methods and compositions involving miRNA and miRNA inhibitor molecules

Methods and compositions involving miRNA and miRNA inhibitor molecules

Aptamer which selectively binds to ERBB2 receptor and uses thereof

Exon skipping compositions for treating muscular dystrophy

Methods and compositions involving miRNA and miRNA inhibitor molecules

Methods and compositions involving miRNA and miRNA inhibitor molecules

Methods and compositions involving miRNA and miRNA inhibitor molecules

Methods and compositions involving miRNA and miRNA inhibitor molecules

Methods and compositions involving miRNA and miRNA inhibitor molecules

Synthesis, deprotection, analysis and purification of RNA and riboz...

2′ Modified oligonucleotides

Polymerase III-based expression of therapeutic RNAS

Synthesis, deprotection, analysis and purification of RNA and riboz...

Base-modified enzymatic nucleic acid

2&#x02032; Modified oligonucleotides

Synthesis, deprotection, analysis and purification of RNA and riboz...

Method and reagent for inhibiting herpes simplex virus replication

Ribozyme treatment of diseases or conditions related to levels of i...

Synthesis, deprotection, analysis and purification for RNA and ribo...

Method and reagent for inhibiting herpes simplex virus replication

Ribozyme treatment of diseases or conditions related to levels of N...

Patents Applicationslast 30 patents

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TRE...

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Antisense Nucleic Acids

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TRE...

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

ANTISENSE NUCLEIC ACIDS

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Treatment Of Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steat...

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

ANTISENSE NUCLEIC ACIDS

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

SYNTHESIS OF HIGH DENSITY MOLECULAR DNA BRUSHES VIA ORGANIC-PHASE R...

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TRE...

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo

Antisense Polynucleotides to Induce Exon Skipping and Method of Tre...

ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TR...

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

SELF-ASSEMBLED, ELECTRONICALLY-FUNCTIONAL NUCLEIC ACID NANOSTRUCTUR...

POLYNUCLEOTIDE AGENTS TARGETING AMINOLEVULINIC ACID SYNTHASE-1 (ALA...

Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

Antisense Polynucleotides to Induce Exon Skipping and Methods of Tr...

APTAMER WHICH SELECTIVELY BINDS TO ERBB2 RECEPTOR AND USES THEREOF

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

2′ Modified oligonucleotides